The Convergent Investors team made founding investments in the following companies:


Encode Bio, Inc.
www.encodebio.com

Encode Bio develops novel screening technologies to detect changes in protein conformations in response to pharmacological agents.

Neurion Pharmaceuticals, Inc.
www.neurionpharma.com

Neurion Pharmaceuticals is a research and development company focused on small molecule drug therapies for diseases and disorders of the central nervous system.

ORFID Corporation
www.orfid.com

ORFID Corporation is an organic electronics company that is developing technology for the display and signage industries.

SiDMAP, LLC*
www.sidmap.com

SiDMAP is developing novel biomarkers for drug development and disease management and provides proprietary metabolic profiling and phenotyping services for industry and academic research.